Conflict of interest statement Within the last 36 months, FK has served on scientific advisory panels and/or been part of speaker's bureaus for, served as a consultant to and/or received research support from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Gubra, MedImmune, MSD/Merck, Mundipharma, Norgine, Novo Nordisk, Sanofi and Zealand Pharma
You should NOT take GLP-1 medications if you have: personal or family history of medullary thyroid carcinoma or MEN2 syndrome, severe gastroparesis, or active pancreatitis
Adipokines and non-alcoholic fatty liver disease: multiple interactions
We prioritize helping our patients understand the latest advancements in diabetes management and weight control
On the Horizon Researchers are writing the story of GLP-1s in real time